Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Check Point Software Technologies shares fall as analyst downgrade adds to growth concerns

None

Check Point Software Technologies (CHKP) is down 3.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is a recent Raymond James downgrade to Market Perform, which appears to have revived investor concerns about weakening channel trends ahead of second-quarter results. The selloff also seems tied to lingering worries from the company’s softer first-quarter revenue performance and a more cautious growth outlook.

Details:

  • Raymond James recently lowered its rating on CHKP from Outperform to Market Perform after citing weaker field and channel checks, giving the market a fresh negative signal on near-term demand.
  • Check Point’s first-quarter 2026 results showed revenue growth, but the release indicated pressure in product sales and hardware-related demand, which had already hurt sentiment earlier this year.
  • The company has scheduled its second-quarter 2026 earnings release for July 30, 2026, which may be keeping investors defensive as they wait to see whether execution and growth improve.
  • Check Point also disclosed a security vulnerability affecting certain Remote Access VPN and Mobile Access configurations in June, and while a fix was released, that event may still be contributing to investor caution around the name.
  • Sources:

    Check Point Software, SEC, Benzinga, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $CHKP Insider Trading Activity

    CHKP Insider Trades

    $CHKP insiders have traded $CHKP stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $CHKP stock by insiders over the last 6 months:

    • YOAV CHELOUCHE sold 25,000 shares for an estimated $3,506,940
    • SHENHAV TAL SHAVIT sold 25,000 shares for an estimated $3,076,747
    • JERRY T UNGERMAN sold 25,000 shares for an estimated $3,063,632

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive CHKP Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $CHKP Hedge Fund Activity

    We have seen 270 institutional investors add shares of $CHKP stock to their portfolio, and 366 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $CHKP Congressional Stock Trading

    Members of Congress have traded $CHKP stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $CHKP stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $CHKP Analyst Ratings

    Wall Street analysts have issued reports on $CHKP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Susquehanna issued a "Positive" rating on 05/01/2026
    • BWG Global issued a "Negative" rating on 04/14/2026

    To track analyst ratings and price targets for $CHKP, check out Quiver Quantitative's $CHKP forecast page.

    $CHKP Price Targets

    Multiple analysts have issued price targets for $CHKP recently. We have seen 18 analysts offer price targets for $CHKP in the last 6 months, with a median target of $150.0.

    Here are some recent targets:

    • Patrick Colville from Scotiabank set a target price of $185.0 on 07/06/2026
    • John Difucci from Guggenheim set a target price of $188.0 on 07/01/2026
    • Keith Bachman from BMO Capital set a target price of $135.0 on 05/04/2026
    • Fatima Boolani from Citigroup set a target price of $125.0 on 05/04/2026
    • Shyam Patil from Susquehanna set a target price of $140.0 on 05/01/2026
    • Peter Levine from Evercore ISI Group set a target price of $130.0 on 05/01/2026
    • Dan Ives from Wedbush set a target price of $160.0 on 05/01/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles